Lorazepam - 10019-106-01 - (Lorazepam)

Alphabetical Index


Drug Information of Lorazepam

Product NDC: 10019-106
Proprietary Name: Lorazepam
Non Proprietary Name: Lorazepam
Active Ingredient(s): 4    mg/mL & nbsp;   Lorazepam
Administration Route(s): INTRAMUSCULAR; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Lorazepam

Product NDC: 10019-106
Labeler Name: BAXTER HEALTHCARE CORPORATION
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018140
Marketing Category: NDA
Start Marketing Date: 20050923

Package Information of Lorazepam

Package NDC: 10019-106-01
Package Description: 25 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-106-01) > 1 mL in 1 VIAL, SINGLE-DOSE (10019-106-44)

NDC Information of Lorazepam

NDC Code 10019-106-01
Proprietary Name Lorazepam
Package Description 25 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-106-01) > 1 mL in 1 VIAL, SINGLE-DOSE (10019-106-44)
Product NDC 10019-106
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lorazepam
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAMUSCULAR; INTRAVENOUS
Start Marketing Date 20050923
Marketing Category Name NDA
Labeler Name BAXTER HEALTHCARE CORPORATION
Substance Name LORAZEPAM
Strength Number 4
Strength Unit mg/mL
Pharmaceutical Classes Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient]

Complete Information of Lorazepam


General Information